Boston Biodevelopment

Founded in 2009, Boston Biodevelopment supplies experienced regulatory leaders who work inside client teams from pre-IND planning through approval. Its services include interim regulatory leadership, global strategy, health-authority meetings, expedited-designation strategy, submission management, due diligence and US-agent support. The team highlights expertise in biologics, small molecules, cell and gene therapies, gene editing and rare disease.